ask="19.89"
ask_size="200"
average_daily_volume="212610"
bid="12.20"
bid_size="600"
book_value="3.21"
change="+0.35"
change_from_200_day_moving_average="7.91"
change_from_50_day_moving_average="4.53"
change_from_52_week_high="-2.36"
change_From_52_week_low="14.56"
change_in_percent="+1.86%"
close="19.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.61"
eps_estimate_next_quarter="-0.71"
eps_estimate_next_year="-2.64"
ex_dividend_date="N/A"
float_shares="6537000"
high="19.94"
high_52_weeks="21.56"
last_trade_date="1/5/2017"
last_trade_price="19.20"
last_trade_size="1735"
last_trade_time="4:00pm"
low="18.73"
low_52_weeks="4.64"
market_capitalization="191.10M"
moving_average_200_day="11.29"
moving_average_50_day="14.67"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.43"
open="19.17"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+70.07%"
percent_change_from_50_day_moving_average="+30.89%"
percent_change_from_52_week_high="-10.96%"
percent_change_from_52_week_low="+313.79%"
previous_close="18.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.88"
price_per_sales="3319.19"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="6.60"
stock_exchange="NGM"
symbol="ZYNE"
volume="436287"
weeks_range_52="4.64 - 21.56"
